Nechemia Jacob Peres

October 13, 2026

Via Announces Q3 2026 Earnings Release Date. Via Transportation Inc. will release its third quarter 2026 financial results on November 9, 2026. The announcement follows the company’s regular earnings cycle and will provide updated performance data for investors. Market participants will watch the results for guidance on revenue, earnings and future outlook.

October 14, 2026

White House AI Policy Move May Impact Taboola's Recommendation Engine. The Trump administration is shifting AI testing agency officials to the White House, aiming to integrate new AI tools into decision‑making. This shift signals a focus on AI policy that could affect how companies like Taboola deploy recommendation algorithms. The move may lead to new regulations or guidelines that impact AI‑driven platforms. Investors may watch for policy changes that influence the broader AI ecosystem.

October 17, 2026

Teva Receives FDA Approval for Weltruza, Announces R&D Day. Teva Pharmaceutical Industries secured FDA approval for Weltruza, a once‑monthly long‑acting injectable for schizophrenia. The approval follows the company’s announcement of an R&D day in New York City, where it will discuss its pipeline and future research plans. Barclays raised its price target to $47, citing the new product launch and potential growth in the schizophrenia market. These developments add fresh catalysts to Teva’s outlook.